Drug Trial Radar · NCT00893841
Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride
Last checked: Nov 19, 2026Latest source record: Feb 4, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
96
Actual
Start
Feb 2009
Primary completion
Jan 2013
Study completion Jan 2013
Sponsor
- Lead sponsor
- Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- AstraZeneca
- First posted
- May 6, 2009
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to assess the use of pramipexole dihydrochloride and quetiapine (Seroquel) XR as combination therapy for bipolar depression. The proposed benefit of the combination therapy investigated in this study is improved treatment of bipolar depression.
Conditions
- Bipolar Depression
Interventions
quetiapine (Seroquel) XRDrug
tablets and caplets, take with liquid before bedtime
quetiapine (Seroquel) XRDrug
tablets, take with liquid before bedtime
placeboDrug
placebo
pramipexole dihydrochlorideDrug
tablets and caplets, take with liquid before bedtime
Primary outcomes
What the sponsor says the trial is designed to measure.
- Montgomery-Asberg Depression Rating Scale (MADRS) total scoreTime frame: Week 0 to Week 16
Locations
9 sites in 2 countries. Site status is shown where the registry gives one.
Affiliated Research Institute
San Diego, California
Eastside Therapeutic Resource
Kirkland, Washington
Dr. P. Chokka
Edmonton, Alberta, Canada
Penticton Regional
Penticton, British Columbia, Canada
Copeman Neuroscience Centre
Vancouver, British Columbia, Canada
AK Munshi Medical Inc.
Sydney, Nova Scotia, Canada
Regional Mental Health Care - London
London, Ontario, Canada
Hôpital Louis-H.Lafontaine
Montreal, Quebec, Canada
Clinique Marie Fitzbach
Québec, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.